New therapeutic strategies for behavioral and psychological symptoms of dementia

Clinical Neurology

Volumn 45, Issue 11, 2005, Pages 861-863

  Ikeda, Manabu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Behavioral and psychological symptoms of dementia (BPSD); Dementia; Dementia with Lewy bodies; Frontotemporal lobar degeneration

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINESTERASE INHIBITOR; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ALZHEIMER DISEASE; BEHAVIOR THERAPY; CAREGIVER; CONFERENCE PAPER; DEMENTED PATIENT; DEMENTIA; FRONTOTEMPORAL DEMENTIA; HOME CARE; HUMAN; LEWY BODY; PATIENT; PATIENT CARE; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; SYMPTOMATOLOGY;

ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; DEMENTIA; HUMANS; LEWY BODY DISEASE; MENTAL DISORDERS;

EID: 31544466515     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Kinkel SI, Costa e Silva J, Cohen G, et al: Behavioral and psychological signs and symptoms of dementia; A consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8 [Suppl. 3]: 497-500
2. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314
3. Ikeda M, Fukuhara R, Shigenobu K, et al: Dementia-associated mental and behavioral disturbances in community dwelling elderly: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry 2004; 75: 146-148
4. Ikeda M, Shigenobu K, Fukuhara R, et al: Delusions of Japanese patients with Alzheimer's disease. Int J Geriatr Psychiatry 2003; 18: 527-532
5. De Deyn PP, Rabheru K, Rasmussen A, et al: A randomized trial of rispeidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999; 53: 946-955
6. Shigenobu K, Ikeda M, Fukuhara R, et al: Reducing the burden of care for Alzheimer's disease through the amelioration of "delusions of theft" by drug therapy. Int J Geriat Psychiatry 2002; 17: 211-217
7. Hirono N, Mori E, Tanimukai S, et al: Distinctive Neurobehavioral features among Neurodegenerative dementias. Neuropsychiatry Ciln Neurosci 1999; 11: 498-503
8. McKeith I, Del Ser T, Spano P, et al: Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-2036
9. Neary D, Snowden JS, Gustafson L, et al: Frontotemporal lobar degeneration-A consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554
10. Swartz JR, Miller BL, Lesser IM, et al: Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997; 58: 212-216
11. Lebert F, Stekke W, Hasenbroekx C, et al: Frontotemporal dementia: A randomized, controlled trial with trazodone. Dement Geriatr Cogn Disord 2004; 17: 355-359
12. Ikeda M, Shigenobu K, Fukuhara R, et al: Efficacy of fluvoxamine as a treatment for behavioral symptoms in FTLD patients. Dement Geriatr Cogn Disord 2004; 17: 117-121
13. Shigenobu K, Ikeda M, Fukuhara R, et al: The Stereotypy Rating Inventory for Frontotemporal Lobar Degeneration. Psychiatry Research 2002; 110: 175-187